T. Rowe Price Associates »

Palvella Therapeutics Inc Ne shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Palvella Therapeutics Inc Ne (PVLA) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Palvella Therapeutics Inc Ne

Tip: Access up to 7 years of quarterly data

All positions including Palvella Therapeutics Inc Ne held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Palvella Therapeutics Inc Ne by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $50M 403k 124.68
2025-12-31 $429k 4.1k 104.89
2025-09-30 $230k 3.7k 62.89

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Palvella Therapeutics Inc Ne

Suvretta Capital Management
First Light Asset Management
BVF
Frazier Life Sciences Management
BlackRock
Jennison Associates
Vanguard Capital Management
State Street Corporation
Federated Investors
T. Rowe Price Associates
Frontier Capital Management
Woodline Partners
Alliancebernstein
Siren
Caption Management

View all funds holding Palvella Therapeutics Inc Ne